Approval for the addition of the cpsa assay to the bayer advia ims system.  The device, as modified, will be marketed under the trade name bayer advia ims cpsa assay and is indicated as an aid in the detection of prostate cancer in men aged 50 years or older in conjunction with digital rectal exam.